Stemphylium solani Allergy Shots: Occupational Exposure and the Alternaria Evidence Link
Stemphylium solani is a Solanaceae plant pathogen — the leaf blight of tomato, potato, and pepper — whose allergy relevance is concentrated in greenhouse and farm workers, not the general population. No species-specific SCIT RCT exists for S. solani; therapeutic decisions borrow from Alternaria DBPC-RCTs (Kuna 2011, Tabar 2019) via shared Pleosporaceae cross-reactivity. Occupational exposure modification is the primary first-line intervention.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Stemphylium solaniis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Stemphylium solani Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to stemphylium solani — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of stemphylium solani allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of stemphylium solani immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of stemphylium solani extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for stemphylium solani allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing stemphylium solani extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription stemphylium solani immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat stemphylium solani allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Stemphylium solani?
The biology, taxonomy, and clinical fingerprint of Stemphylium solani — the foundation of how SCIT targets it.
Stemphylium solani causes gray leaf spot on tomato and potato crops; greenhouse workers are the primary population at risk for occupational sensitization.
- Scientific name
- Stemphylium solani
- Family
- PleosporaceaePleosporales family
- Type
- Occupational agricultural mold spore
- Native to
- Subtropical/tropical Solanaceae-growing regions — Brazil, Florida, Caribbean, southern India
- Allergen proteins
- No WHO/IUIS-registered S. solani allergens as of 2024Family-level cross-reactivity via Alt a 1 and Alt a 4 (PDI) homologues assumed
- Particle size
- Muriform dark phragmospores, characteristic Stemphylium morphology
- Avoidance difficulty
- Nearly impossible
How Stemphylium solani Allergy Presents
Symptoms by body system — useful for distinguishing Stemphylium solani sensitivity from overlapping allergies and infections.
Respiratory
- Occupational rhinitis during tomato and pepper harvesting
- Asthma exacerbations in greenhouse workers during dry pruning seasons
- Bronchospasm triggered by conidial aerosols in poorly ventilated greenhouses
- Persistent cough in farm laborers with heavy Solanaceae exposure
Ocular
- Occupational conjunctivitis during harvest
- Itchy, red eyes when handling infected plant material
- Tearing and blurred vision during peak exposure
Dermal
- Skin sensitization from direct contact with infected leaves
- Contact urticaria in susceptible workers handling moldy plant material
- Non-specific dermatitis in heavily exposed workers
Systemic
- Fatigue in workers with chronic occupational mold exposure
- Headache associated with nasal congestion
- Reduced work capacity from recurrent respiratory symptoms
- Sleep disruption from poorly controlled occupational rhinitis
For greenhouse tomato workers, the first question I ask about a Stemphylium solani positive is not which immunotherapy to start — it is what the working conditions look like. Improved ventilation, N95 use during pruning, and job rotation often produce more symptom relief than any injection protocol. When those are already in place and symptoms persist, then we discuss the Alternaria-family SCIT option.
When & Where Stemphylium solani Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak exposure: tomato and pepper harvest season, typically August through October in temperate Solanaceae-growing regions· Occupational exposure duration varies by crop cycle and greenhouse management; greenhouse workers may face year-round low-level exposure
US Exposure Map
3 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- Low
- MT:
- Low
- ND:
- Low
- MN:
- Low
- WI:
- Low
- MI:
- Moderate
- NY:
- Low
- MA:
- Low
- OR:
- Low
- ID:
- Low
- WY:
- Low
- SD:
- Low
- IA:
- None
- IL:
- Low
- IN:
- Moderate
- OH:
- Moderate
- PA:
- Low
- NJ:
- Low
- CT:
- Low
- RI:
- Low
- CA:
- High
- NV:
- Low
- UT:
- Low
- CO:
- Low
- NE:
- Low
- MO:
- Low
- KY:
- Low
- WV:
- Low
- VA:
- Low
- MD:
- Low
- DE:
- Low
- AZ:
- Low
- NM:
- Low
- KS:
- Low
- AR:
- Low
- TN:
- Low
- NC:
- Moderate
- SC:
- Low
- OK:
- None
- LA:
- Low
- MS:
- Low
- AL:
- Low
- GA:
- Moderate
- TX:
- High
- FL:
- High
- AK:
- Low
- HI:
- Low
What Stemphylium solani Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Stemphylium solani shares Pleosporaceae family-level allergen cross-reactivity with Alternaria via Alt a 1 and Alt a 4 (protein disulfide isomerase) homologues, though no species-specific allergen proteins have been characterized for S. solani (Olivieri 2003).
Is SCIT Right for Your Stemphylium solani Allergy?
Answer five questions to assess whether your Stemphylium solani / Pleosporaceae sensitization — especially in an occupational context — warrants an allergist evaluation for SCIT.
How severe are your work-related mold symptoms (rhinitis, asthma) during or after greenhouse or field work?
The Stemphylium solani SCIT Protocol
When Stemphylium solani sensitization is confirmed and occupational exposure modification has been optimized, SCIT is administered via Alternaria-based extract — the Pleosporaceae family-level evidence anchor. No S. solani-specific vial exists; build-up timing should ideally precede the harvest season by several months so that patients reach maintenance before peak occupational exposure.
Weekly escalating doses of non-standardized Alternaria extract, with the first injection from each new vial or concentration supervised live in the Virtual Shot Room by trained Curex clinical staff and a prescribed epinephrine auto-injector confirmed on hand. For occupational patients, build-up timing is ideally pre-harvest (spring months before the August-October Solanaceae harvest peak). Mold vials are kept separate from pollen vials to prevent protease degradation.
Maintenance continues on a schedule individualized by your allergist once the target dose is reached. Concurrent occupational health follow-up for PPE compliance and exposure monitoring is recommended throughout the maintenance phase.
After completing 3-5 years of maintenance, the allergist assesses lasting symptom control and sensitization trajectory. For workers with ongoing heavy occupational exposure, extended courses may be needed.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Stemphylium solani SCIT
No SCIT-specific RCT has been published for Stemphylium solani. Evidence is borrowed from Alternaria DBPC-RCTs based on shared Pleosporaceae family membership and cross-reactive allergen proteins.
- Alternaria SCIT: Combined symptom-medication score reduction (year 3)63%Kuna et al., J Allergy Clin Immunol 2011, N=111 children, DBPC-RCT
- Alternaria SCIT: Improvement after 1 year (purified Alt a 1)40%Tabar et al., J Allergy Clin Immunol 2019, native Alt a 1 DBPC-RCT
No published SCIT RCT targets Stemphylium solani specifically. Therapeutic decisions for confirmed Pleosporaceae sensitization extrapolate from the Alternaria SCIT evidence base. For occupational patients, the evidence hierarchy places exposure modification (PPE, ventilation, job rotation) ahead of SCIT unless occupational controls are infeasible or already optimized.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Stemphylium solani SCIT Side Effects
Side effects of Alternaria-based mold SCIT follow the standard SCIT safety profile. Mold extracts contain proteases that can cause higher rates of local reactions than pollen extracts.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection site swelling and erythema Typical wheal-and-flare response peaking 15-20 minutes post-injection | Rate 30-50% | Mild |
Large local reaction Swelling >5 cm at injection site; protease-rich mold extracts increase this risk | Rate 10-20% | Moderate |
Injection site itching Usually brief; topical antihistamine cream can help | Rate 20-40% | Mild |
Delayed local swelling Appears 4-12 hours post-injection; typically resolves without treatment | Rate 5-15% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Rhinitis or conjunctivitis flare Within 30 minutes of injection; antihistamine pre-treatment may help | Rate 0.5-1% | Mild |
Urticaria Requires antihistamine treatment; dose reduction at next visit | Rate 0.1-0.5% | Moderate |
Asthma exacerbation Pre-injection peak flow check mandatory; do not inject if below 80% personal best | Rate 0.1-0.3% | Severe |
Anaphylaxis Curex supervises the first injection from each new vial or concentration live in the Virtual Shot Room with a prescribed epinephrine auto-injector confirmed on hand | Rate <0.01% | Severe |
Mold SCIT carries a real safety record when epinephrine is available and dosing is supervised. Curex delivers it at home with a USP <797> serum, a Virtual Shot Room–supervised the first injection from each new vial or concentration, a prescribed epinephrine auto-injector confirmed on hand, and allergist-overseen escalation. Occupational patients with active asthma require pre-injection peak flow measurement.
SCIT vs Alternatives for Stemphylium solani
For Stemphylium solani occupational sensitization, management options include occupational exposure control (first-line), Alternaria-family SCIT (when controls are insufficient), at-home SLIT drops, and daily pharmacotherapy.
| Criterion | At-Home SCIT (Curex, Alternaria-based)Best | SLIT drops | Exposure control | Medications |
|---|---|---|---|---|
| Effectiveness | 63% combined score reduction (Kuna 2011) for Pleosporaceae | Alternaria SLIT shows improvement (Cortellini 2010); limited mold data | Significant for occupational cases with heavy exposure | Symptomatic relief only |
| 5-yr cost | $3,500-$8,000 over 5 years | $500-$2,000/yr | PPE/ventilation costs vary | $500-$2,000/yr ongoing |
| Duration | 3-5 years | 3-5 years | Ongoing workplace modification | Ongoing daily use |
| Convenience | At-home self-injection; weekly then monthly | Daily at-home drops | Requires employer cooperation | Daily pills/sprays |
| Safety | Systemic reactions <1%; Virtual Shot Room–supervised dosing + prescribed epi | Lower systemic reaction risk than SCIT | No injection risks | Drug side effects with long-term use |
| Lasting effect | Yes — tolerance may persist after treatment | Evidence less robust than SCIT for molds | Effective while controls are in place | No lasting effect |
At-Home SCIT (Curex, Alternaria-based)Best
SLIT drops
Exposure control
Medications
For occupational Solanaceae workers, exposure modification is the most effective first step. When that is insufficient, Alternaria-family SCIT provides the strongest evidence-based immunotherapy option. Curex now delivers that Alternaria-family SCIT as an at-home allergy shot with pricing confirmed in a current program quote: a serum compounded under USP <797>, with the first injection from each new vial or concentration supervised live in the Virtual Shot Room, a prescribed epinephrine auto-injector confirmed on hand, and allergist-overseen escalation — so workers who cannot make weekly clinic visits can still pursue evidence-based immunotherapy.
What Stemphylium solani SCIT Actually Costs
Workers' compensation or occupational health coverage may apply for confirmed occupational mold allergy in greenhouse and agricultural workers. Standard allergy benefits with a board-certified allergist referral typically cover SCIT injections and extract preparation. Curex at-home IgE testing identifies specific stemphylium solani sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your stemphylium solani allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Stemphylium solani SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
A positive Stemphylium solani test in a greenhouse worker is primarily an occupational health finding. The first-line response is workplace exposure control: N95 respirator use during pruning and harvesting, improved greenhouse ventilation, mechanized harvesting where feasible, and job rotation for symptomatic workers. These measures are supported by NIOSH agricultural respiratory protection guidelines and often produce meaningful symptom relief. Once exposure controls are in place, a board-certified allergist can assess whether the remaining symptom burden warrants Alternaria-family SCIT. The allergist should also confirm co-sensitization to Alternaria via ImmunoCAP m6 and rAlt a 1 component testing.
No published clinical trial has evaluated Stemphylium solani as a standalone SCIT antigen. In US practice, commercially available Stemphylium extracts are non-standardized and not the basis for a dedicated SCIT protocol. When SCIT is appropriate for confirmed Pleosporaceae sensitization that includes Stemphylium solani, the treatment uses Alternaria-based extract — supported by Kuna 2011 JACI and Tabar 2019 JACI as the family-level RCT evidence. Your allergist may incorporate a Stemphylium extract alongside Alternaria in a mold mix vial, but the dose-titration and evidence anchor is Alternaria.
No — tomato food allergy and Stemphylium solani aeroallergen sensitization are separate clinical entities. Tomato food allergy involves IgE to tomato proteins such as the lipid transfer protein Sola l 3, profilin, and other fruit-specific allergens (San Miguel-Moncín 2003). Stemphylium solani sensitization involves IgE to fungal proteins (Pleosporaceae allergen homologues). The fact that S. solani is a tomato leaf pathogen does not create a clinical link between the two allergies. If you have both tomato food reactions and occupational Stemphylium symptoms, your allergist will evaluate them as independent sensitizations requiring separate evaluation and management.
Stemphylium solani is geographically and occupationally concentrated — it is the Solanaceae crop pathogen relevant to greenhouse tomato, potato, and pepper workers in subtropical regions. Stemphylium botryosum is the broader-temperate alfalfa and grass blight pathogen with more widespread aerobiology relevant to the general population. Both share similar Pleosporaceae allergen cross-reactivity with Alternaria. For practical allergy management, the distinction matters primarily in determining who the at-risk patient is: general temperate-region population for botryosum, or Solanaceae agricultural workers for solani. The SCIT approach (Alternaria-family extract) is the same for both.
For mild-to-moderate occupational Stemphylium solani allergy, antihistamines and intranasal corticosteroids often provide adequate symptom control when combined with exposure modification. Second-generation antihistamines (cetirizine, loratadine, fexofenadine) and nasal corticosteroids (fluticasone, mometasone) are the first-line pharmacotherapy per AAAAI/ACAAI guidelines. SCIT is typically reserved for patients whose symptoms break through optimal pharmacotherapy despite exposure controls, patients with occupational asthma that is difficult to control, or those who prefer a longer-term solution that may reduce medication dependence. A board-certified allergist can help you determine which step on the treatment ladder is appropriate for your case.
Specific IgE blood testing for Stemphylium solani (and the related Alternaria m6 ImmunoCAP, plus rAlt a 1 component) can be ordered via at-home blood draw kits and processed by a laboratory. Skin prick testing requires an in-clinic visit. For occupational patients who have limited availability during peak growing season, at-home blood testing is a practical way to confirm Pleosporaceae sensitization without disrupting work. Skin prick testing in-office may be recommended as a follow-up for treatment planning.
Grain fever and organic dust toxic syndrome (ODTS) are non-allergic febrile syndromes caused by heavy inhalation of organic dust — including fungal spores, endotoxin, and grain particles — without an IgE-mediated mechanism. They produce fever, chills, muscle aches, and malaise 4-12 hours after exposure, resolving spontaneously within 24-48 hours. IgE-mediated Stemphylium allergy produces immediate (within minutes) rhinitis, conjunctivitis, or asthma triggered by fungal spore exposure. Both can coexist in the same agricultural worker. Distinguishing them requires clinical history and, for ODTS, the absence of specific IgE to the offending agent.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.